| Ident. | Authors (with country if any) | Title |
|---|
| 000160 (2018) |
Daniil A. Korenkov [Russie] ; Karen L. Laurie [Australie] ; Patrick C. Reading [Australie] ; Louise A. Carolan [Australie] ; Kok Fei Chan [Australie] ; Irina I. Isakova-Sivak [Russie] ; Tatiana A. Smolonogina [Russie] ; Kanta Subbarao [Australie] ; Ian G. Barr [Australie] ; Julie Villanueva [États-Unis] ; Svetlana Shcherbik [États-Unis] ; Tatiana Bousse [États-Unis] ; Larisa G. Rudenko [Russie] | Safety, immunogenicity and protection of A(H3N2) live attenuated influenza vaccines containing wild-type nucleoprotein in a ferret model. |
| 000533 (2015) |
Larisa Rudenko [Russie] ; Irina Isakova-Sivak | Pandemic preparedness with live attenuated influenza vaccines based on A/Leningrad/134/17/57 master donor virus. |
| 000561 (2015) |
Irina Isakova-Sivak [Russie] ; Marina Stukova [Russie] ; Mariana Erofeeva [Russie] ; Anatoly Naykhin [Russie] ; Svetlana Donina [Russie] ; Galina Petukhova [Russie] ; Victoria Kuznetsova [Russie] ; Irina Kiseleva [Russie] ; Tatiana Smolonogina [Russie] ; Irina Dubrovina [Russie] ; Maria Pisareva [Russie] ; Alexandra Nikiforova [Russie] ; Maureen Power [États-Unis] ; Jorge Flores [États-Unis] ; Larisa Rudenko [Russie] | H2N2 live attenuated influenza vaccine is safe and immunogenic for healthy adult volunteers |
| 000691 (2014) |
Gerald Aichinger [Autriche] ; Barbara Grohmann-Izay [Autriche] ; Maikel V. W. Van Der Velden [Autriche] ; Sandor Fritsch [Autriche] ; Manuela Koska [Autriche] ; Daniel Portsmouth [Autriche] ; Mary Kate Hart [États-Unis] ; Wael El-Amin [États-Unis] ; Otfried Kistner [Autriche] ; P. Noel Barrett [Autriche] | Phase I/II Randomized Double-Blind Study of the Safety and Immunogenicity of a Nonadjuvanted Vero Cell Culture-Derived Whole-Virus H9N2 Influenza Vaccine in Healthy Adults |
| 000A27 (2012) |
Filippo Ansaldi [Italie] ; Laura Valle ; Daniela De Florentiis ; Valentina Parodi ; Giuseppe Murdaca ; Bianca Bruzzone ; Paolo Durando ; Maurizio Setti ; Giancarlo Icardi | Phase 4 randomized trial of intradermal low-antigen-content inactivated influenza vaccine versus standard-dose intramuscular vaccine in HIV-1-infected adults. |
| 000A76 (2012) |
Alexandra S. Gambaryan [Russie] ; Natalia F. Lomakina ; Elizaveta Y. Boravleva ; Ekaterina A. Kropotkina ; Vadim V. Mashin ; Igor V. Krasilnikov ; Alexander I. Klimov ; Larisa G. Rudenko | Comparative safety, immunogenicity, and efficacy of several anti-H5N1 influenza experimental vaccines in a mouse and chicken models (Testing of killed and live H5 vaccine). |
| 000A85 (2012) |
Kawsar R. Talaat ; Ruth A. Karron ; Philana H. Liang ; Bridget A. Mcmahon ; Catherine J. Luke ; Bhagvanji Thumar ; Grace L. Chen ; Ji-Young Min ; Elaine W. Lamirande ; Hong Jin ; Kathy L. Coelingh ; George W. Kemble ; Kanta Subbarao | An open‐label phase I trial of a live attenuated H2N2 influenza virus vaccine in healthy adults |
| 000C38 (2011) |
Larisa Rudenko [Russie] ; Han Van Den Bosch ; Irina Kiseleva ; Alexander Mironov ; Anatoly Naikhin ; Natalie Larionova ; Dimitry Bushmenkov | Live attenuated pandemic influenza vaccine: clinical studies on A/17/California/2009/38 (H1N1) and licensing of the Russian-developed technology to WHO for pandemic influenza preparedness in developing countries. |
| 000D93 (2010) |
N A Mazurkova ; N N Ryndiuk ; L N Shishkina ; V A Ternovo ; Iu V. Tumanov ; L E Bulychev ; M O Skarnovich ; A S Kabanov ; S G Panchenko ; R P Ale Nikov ; T N Il'Ina ; V I Kuzubov ; S Ia Mel'Nikov ; A N Mironov ; S A Korovkin ; A N Sergeev ; I G Drozdov | [Results of clinical trials on reactogenicity, safety, and immunogenicity of influenza allantoic intranasal live vaccine "Ultragrivac" (type A/H5N2)]. |
| 000E85 (2010) |
Pierre Van Damme [Belgique] ; Robert Arnou ; Froukje Kafeja ; Anne Fiquet ; Patrick Richard ; Stéphane Thomas ; Gilles Meghlaoui ; Sandrine Isabelle Samson ; Emilio Ledesma | Evaluation of non-inferiority of intradermal versus adjuvanted seasonal influenza vaccine using two serological techniques: a randomised comparative study. |
| 000F07 (2010) |
Ji-Young Min [États-Unis] ; Leatrice Vogel ; Yumiko Matsuoka ; Bin Lu ; David Swayne ; Hong Jin ; George Kemble ; Kanta Subbarao | A live attenuated H7N7 candidate vaccine virus induces neutralizing antibody that confers protection from challenge in mice, ferrets, and monkeys. |
| 001044 (2009) |
Grace L. Chen [États-Unis] ; Elaine W. Lamirande [États-Unis] ; Hong Jin [États-Unis] ; George Kemble [États-Unis] ; Kanta Subbarao [États-Unis] | Safety, Immunogencity and Efficacy of a Cold-Adapted A/Ann Arbor/6/60 (H2N2) Vaccine in Mice and Ferrets |
| 001081 (2009) |
Terho Heikkinen ; Ville Peltola | Influenza vaccination of children. |
| 001132 (2009) |
Kawsar R. Talaat [États-Unis] ; Ruth A. Karron ; Karen A. Callahan ; Catherine J. Luke ; Susan C. Dilorenzo ; Grace L. Chen ; Elaine W. Lamirande ; Hong Jin ; Kathy L. Coelingh ; Brian R. Murphy ; George Kemble ; Kanta Subbarao | A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults. |
| 001225 (2008) |
Larisa Rudenko [Russie] ; Julia Desheva ; Sergey Korovkin ; Alexander Mironov ; Andrey Rekstin ; Elena Grigorieva ; Svetlana Donina ; Alexandra Gambaryan ; Anton Katlinsky | Safety and immunogenicity of live attenuated influenza reassortant H5 vaccine (phase I-II clinical trials). |
| 001496 (2006) |
Kwang-Hee Lee [Corée du Sud] ; Sang-Uk Seo ; Jae-Min Song ; Chung-Min Lee ; Hyun-Ah Kim ; Baik L. Seong | Characterization of live influenza vaccine donor strain derived from cold-adaptation of X-31 virus. |
| 001790 (2002) |
W. E. P. Beyer [Pays-Bas] ; A. M. Palache [Pays-Bas] ; J. C. De Jong [Pays-Bas] ; A. D. M. E. Osterhaus [Pays-Bas] | Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy A meta-analysis |
| 001E68 (1993) |
Louis F. Fries [États-Unis] ; Susan B. Dillon [États-Unis] ; James E. K. Hildreth [États-Unis] ; Ruth A. Karron [États-Unis] ; Ann W. Funkhouser [États-Unis] ; Carl J. Friedman [États-Unis] ; Christopher S. Jones [États-Unis] ; Vasantha G. Culleton [États-Unis] ; Mary Lou Clements [États-Unis] | Safety and Immunogenicity of a Recombinant Protein Influenza A Vaccine in Adult Human Volunteers and Protective Efficacy against Wild-Type H1N1 Virus Challenge |
| 002064 (1990) |
H. Závadová [République tchèque] ; E. Domorázková ; J. Skovránková ; M. Vodicková ; P. Ragac ; V. Vonka | [Reactivity and immunologic activity of polyvalent split influenza vaccine in children]. |
| 002137 (1989) |
M L Clements [États-Unis] ; S D Sears ; K. Christina ; B R Murphy ; M H Snyder | Comparison of the virologic and immunologic responses of volunteers to live avian-human influenza A H3N2 reassortant virus vaccines derived from two different avian influenza virus donors. |
| 002264 (1988) |
Robert F. Betts [États-Unis] ; R. Gordon Douglas ; Hunien F. Maassab Jr. ; Dan C. Deborde ; Mary Lou Clements [États-Unis] ; Brian R. Murphy | Analysis of virus and host factors in a study of A/Peking/2/79 (H3N2) cold‐adapted vaccine recombinant in which vaccine‐associated illness occurred in normal volunteers |
